Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)
Vossen, L.M.; Schurgers, L.J.; Van Varik, B.J.; Kietselaer, B.L.J.H.; Vermeer, C.; Meeder, J.G.; Rahel, B.M.; Van Cauteren, Y.J.M.; Hoffland, G.A.; Rennenberg, R.J.M.W.; Reesink, K.D.; De Leeuw, P.W.; Kroon, A.A. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial). Nutrients 2015, 7, 8905-8915. https://doi.org/10.3390/nu7115443
Vossen LM, Schurgers LJ, Van Varik BJ, Kietselaer BLJH, Vermeer C, Meeder JG, Rahel BM, Van Cauteren YJM, Hoffland GA, Rennenberg RJMW, Reesink KD, De Leeuw PW, Kroon AA. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial). Nutrients. 2015; 7(11):8905-8915. https://doi.org/10.3390/nu7115443
Chicago/Turabian StyleVossen, Liv M., Leon J. Schurgers, Bernard J. Van Varik, Bas L.J.H. Kietselaer, Cees Vermeer, Johannes G. Meeder, Braim M. Rahel, Yvonne J.M. Van Cauteren, Ge A. Hoffland, Roger J.M.W. Rennenberg, Koen D. Reesink, Peter W. De Leeuw, and Abraham A. Kroon. 2015. "Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)" Nutrients 7, no. 11: 8905-8915. https://doi.org/10.3390/nu7115443